Parkinson’s case counts varied by method in UK Biobank
Hospital and death records identified about 20% fewer Parkinson’s cases than a drug-based method over 15 years of follow-up.

Our read
Biomarkers- Studied:
- Preprint: cohort study of UK Biobank participants, 15 years of follow-up, against a drug-based method
- What changed:
- Hospital and death records identified about 20% fewer Parkinson's cases than a drug-based method over 15 years of follow-up
- The catch:
- Primary care records covered about 45% of participants, limiting the drug-based method
Editor of record: Boris Djordjevic · AgingResearch.News
UK Biobank participants were studied in an observational comparison of three ways to identify Parkinson’s disease. Researchers compared hospital and death records with general practitioner diagnoses and a new method using drug records.
Hospital and death records dated diagnosis a median 4.2 years after Parkinson’s drugs were started. They underestimated disease incidence by 36% compared with UK reference rates, while the drug-based method yielded rates consistent with those references. Estimates of links with sex, walking speed and mortality also differed between these methods. General practitioner diagnoses and the drug-based method yielded similar findings. However, both diagnosis-based approaches included people with other causes of Parkinson’s-like movement symptoms.
Why it matters
For research on Parkinson’s disease, an age-related disorder, the authors suggest combining data sources to improve the validity of studies of disease risk and mortality.
Caveats
Primary care records covered about 45% of participants, limiting where the drug-based method could be applied within UK Biobank. The preprint has not been peer-reviewed.
The paper
Improving UK Biobank algorithms for Parkinson's disease ascertainment using drug claims
Inserm
medRxiv, Nov 20, 2026, Open access, Preprint, not yet peer-reviewed
Comments
Be the first to comment.